The initial group of 1, 000 will participate in a series of baselinestudies including cardiac function, testing for joint abnormalities and psychosocial tests.
The government estimates 1 in 33 babies are born with birth defects regardless of medication use during pregnancy, and studies eventually concluded that Bendectin didn't increase that baseline risk.